Drug For Breast Cancer
- All
- News
- Videos
-
AstraZeneca Pharma's Cancer-Treating Drug Gets Regulator's Nod In India
AstraZeneca Pharma India Ltd on Wednesday said it has received an approval from the Drug Controller General of India (DCGI) for the cancer drug trastuzumab deruxtecan for treatment of metastatic breast cancer.
-
AstraZeneca India Gets Approval To Market Drug Treating Breast Cancer
Drug firm AstraZeneca India on Friday said it has received an approval from the Drugs Controller General of India to market its drug for the treatment of breast cancer.
-
Can DNA Tests Help Prescribe Antidepressants?
Doctors increasingly use information about genes to evaluate potential risk for some diseases, such as BRCA genes that are linked to breast cancer, and to determine the best drug treatment for diseases, including acute leukemia and HIV. But using pharmacogenetics to help treat depression remains controversial.
-
Breast Cancer Drugs Useful In Treating Drug-Resistant Lung Tumours
A class of drugs used to treat certain breast cancers could help tackle lung cancers that have become resistant to targeted therapies, suggests a study done on mice.
-
Depression Drug Cuts Joint Pain For Women With Breast Cancer: Study
New York: A drug typically used to treat depression and anxiety can significantly reduce joint pain in postmenopausal women being treated for early stage breast cancer, says a study. The researches conducted a trial to test whether duloxetine, a depression and anxiety drug, could alleviate pain caused by aromatase inhibitors, a common breast cance...
-
Combo Therapy Against: Ovarian And Breast Cancer, Can Overcome Drug Resistance
Bolstering the know how behind targeted cancer treatment, Indian scientists have offered a new rationale for combination drug therapy for ovarian and breast cancer, which they say can counter drug resistance and reduce side-effects.
-
European Advisory Panel Recommends Nod For Pfizer Breast Cancer Drug
US drug maker Pfizer Inc's breast cancer drug, Ibrance, should be given marketing approval, an advisory committee at the European Medicines Agency recommended.
-
Biocon's Cancer Drug Accepted For Review, Shares Hit 52-Week High
Biocon shares jumped 5 per cent to their 52-week high on Friday after the drugmaker announced that the European regulator has accepted for review a breast cancer biosimilar jointly developed with Mylan. Biocon and American-Dutch Mylan are exclusive partners on a broad portfolio of biosimilars and insulin analogs.
-
Diabetes Drug May Help Some Patients Beat Breast Cancer
A drug commonly used as the front-line treatment for Type-2 diabetes improves survival for some breast cancer patients, says a study.
-
Women At High Risk For Breast Cancer Reject Preventive Drugs
Five in six women with increased risk of breast cancer turn down drugs likely to prevent the disease, a new study has found.
-
Breast Cancer Drug May Protect Against Killer Superbugs: Study
A common breast cancer drug could wipe out an antibiotic-resistant notorious superbug responsible for several difficult-to-treat infections in different parts of the body, according to a new research.
-
Artificial Intelligence Could Improve Breast Cancer Treatment
"Artificial intelligence is a powerful tool for predicting drug outcomes because it looks at the sum of all the interacting genes."
-
Cheap Osteoporosis Drug Could Prevent a Sixth of Breast Cancer Deaths
Study finds bisphosponates, which only cost 5p a day per patient, reduced risk of dying from breast cancer for postmenopausal women.
-
Biocon, Mylan get DGCA nod for breast cancer drug
Biocon Ltd said on Tuesday it has won approval from the Drug Controller General of India (DGCA) for marketing a generic version of Roche's Herceptin, used in breast cancer treatment.
-
Roche gives up on India patent for breast cancer drug
Roche Holding has decided not to pursue a patent application for its breast cancer drug Herceptin in India, the Swiss company said on Friday, as Western drug makers come under pressure over high prices in the fast-growing market.
-
AstraZeneca Pharma's Cancer-Treating Drug Gets Regulator's Nod In India
AstraZeneca Pharma India Ltd on Wednesday said it has received an approval from the Drug Controller General of India (DCGI) for the cancer drug trastuzumab deruxtecan for treatment of metastatic breast cancer.
-
AstraZeneca India Gets Approval To Market Drug Treating Breast Cancer
Drug firm AstraZeneca India on Friday said it has received an approval from the Drugs Controller General of India to market its drug for the treatment of breast cancer.
-
Can DNA Tests Help Prescribe Antidepressants?
Doctors increasingly use information about genes to evaluate potential risk for some diseases, such as BRCA genes that are linked to breast cancer, and to determine the best drug treatment for diseases, including acute leukemia and HIV. But using pharmacogenetics to help treat depression remains controversial.
-
Breast Cancer Drugs Useful In Treating Drug-Resistant Lung Tumours
A class of drugs used to treat certain breast cancers could help tackle lung cancers that have become resistant to targeted therapies, suggests a study done on mice.
-
Depression Drug Cuts Joint Pain For Women With Breast Cancer: Study
New York: A drug typically used to treat depression and anxiety can significantly reduce joint pain in postmenopausal women being treated for early stage breast cancer, says a study. The researches conducted a trial to test whether duloxetine, a depression and anxiety drug, could alleviate pain caused by aromatase inhibitors, a common breast cance...
-
Combo Therapy Against: Ovarian And Breast Cancer, Can Overcome Drug Resistance
Bolstering the know how behind targeted cancer treatment, Indian scientists have offered a new rationale for combination drug therapy for ovarian and breast cancer, which they say can counter drug resistance and reduce side-effects.
-
European Advisory Panel Recommends Nod For Pfizer Breast Cancer Drug
US drug maker Pfizer Inc's breast cancer drug, Ibrance, should be given marketing approval, an advisory committee at the European Medicines Agency recommended.
-
Biocon's Cancer Drug Accepted For Review, Shares Hit 52-Week High
Biocon shares jumped 5 per cent to their 52-week high on Friday after the drugmaker announced that the European regulator has accepted for review a breast cancer biosimilar jointly developed with Mylan. Biocon and American-Dutch Mylan are exclusive partners on a broad portfolio of biosimilars and insulin analogs.
-
Diabetes Drug May Help Some Patients Beat Breast Cancer
A drug commonly used as the front-line treatment for Type-2 diabetes improves survival for some breast cancer patients, says a study.
-
Women At High Risk For Breast Cancer Reject Preventive Drugs
Five in six women with increased risk of breast cancer turn down drugs likely to prevent the disease, a new study has found.
-
Breast Cancer Drug May Protect Against Killer Superbugs: Study
A common breast cancer drug could wipe out an antibiotic-resistant notorious superbug responsible for several difficult-to-treat infections in different parts of the body, according to a new research.
-
Artificial Intelligence Could Improve Breast Cancer Treatment
"Artificial intelligence is a powerful tool for predicting drug outcomes because it looks at the sum of all the interacting genes."
-
Cheap Osteoporosis Drug Could Prevent a Sixth of Breast Cancer Deaths
Study finds bisphosponates, which only cost 5p a day per patient, reduced risk of dying from breast cancer for postmenopausal women.
-
Biocon, Mylan get DGCA nod for breast cancer drug
Biocon Ltd said on Tuesday it has won approval from the Drug Controller General of India (DGCA) for marketing a generic version of Roche's Herceptin, used in breast cancer treatment.
-
Roche gives up on India patent for breast cancer drug
Roche Holding has decided not to pursue a patent application for its breast cancer drug Herceptin in India, the Swiss company said on Friday, as Western drug makers come under pressure over high prices in the fast-growing market.
